(Q45393077)

14 December 2017

title

Health-related quality of life and cognitive functioning in long-term anaplastic oligodendroglioma and oligoastrocytoma survivors (English)

1 reference

anaplastic oligodendroglioma

14 December 2017

1 reference

1 reference

1 reference

1 reference

adult oligodendroglioma

1 reference

7

Andrew Bottomley

1 reference

14 December 2017

15

Jaap C Reijneveld

1 reference

14 December 2017

4

Martin Klein

1 reference

14 December 2017

Esther J J Habets

1

1 reference

14 December 2017

Martin J B Taphoorn

2

1 reference

14 December 2017

Sylvie Nederend

3

1 reference

14 December 2017

Daniel Delgadillo

5

1 reference

14 December 2017

Khê Hoang-Xuan

6

1 reference

14 December 2017

Anouk Allgeier

8

1 reference

14 December 2017

Tatjana Seute

9

1 reference

14 December 2017

Anja M M Gijtenbeek

10

1 reference

14 December 2017

Jan de Gans

11

1 reference

14 December 2017

Roelien H Enting

12

1 reference

14 December 2017

Cees C Tijssen

13

1 reference

14 December 2017

Martin J van den Bent

14

1 reference

14 December 2017

publication date

26 October 2013

1 reference

Journal of Neuro-Oncology

14 December 2017

published in

1 reference

14 December 2017

volume

116

1 reference

14 December 2017

issue

1

1 reference

14 December 2017

page(s)

161-168

1 reference

https://scigraph.springernature.com/pub.10.1007/s11060-013-1278-0

14 December 2017

exact match

0 references

cites work

Adjuvant procarbazine, lomustine, and vincristine chemotherapy in newly diagnosed anaplastic oligodendroglioma: long-term follow-up of EORTC brain tumor group study 26951.

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1278-0

Phase III trial of chemoradiotherapy for anaplastic oligodendroglioma: long-term results of RTOG 9402.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1278-0

Proposal of a scoring scale as a survival predictor in intracranial oligodendrogliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1278-0

Survival of European patients with central nervous system tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1278-0

Surviving glioblastoma for more than 5 years: the patient's perspective.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1278-0

Neurocognitive and sociodemographic functioning of glioblastoma long-term survivors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1278-0

Cognition and quality of life after chemotherapy plus radiotherapy (RT) vs. RT for pure and mixed anaplastic oligodendrogliomas: radiation therapy oncology group trial 9402.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1278-0

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1278-0

Cognitive deficits before treatment among patients with brain tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1278-0

Cognitive and radiological effects of radiotherapy in patients with low-grade glioma: long-term follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1278-0

The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1278-0

The development and psychometric validation of a brain cancer quality-of-life questionnaire for use in combination with general cancer-specific questionnaires

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1278-0

The evaluation of the Center for Epidemiologic Studies Depression (CES-D) scale: Depressed and Positive Affect in cancer patients and healthy reference subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1278-0

Dimensional assessment of chronic fatigue syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1278-0

The use of significant others as proxy raters of the quality of life of patients with brain cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1278-0

Normative data for the EORTC QLQ-C30 and EORTC-sexuality items in the general Dutch population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1278-0

Assessment of fatigue among working people: a comparison of six questionnaires

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1278-0

Quality of life in patients with intracranial tumors on the basis of Karnofsky's performance status

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1278-0

The course of neurocognitive functioning in high-grade glioma patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1278-0

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1278-0

Adjuvant procarbazine, lomustine, and vincristine improves progression-free survival but not overall survival in newly diagnosed anaplastic oligodendrogliomas and oligoastrocytomas: a randomized European Organisation for Research and Treatment [...]

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1278-0

Cognitive deficits in adult patients with brain tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1278-0

Prospective study of neuropsychologic testing and quality-of-life assessment of adults with primary malignant brain tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1278-0

Cognitive dysfunction following surgery for intracerebral glioma: influence of histopathology, lesion location, and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1278-0

Cognitive functioning in long-term survivors of high-grade glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1278-0

Effect of radiotherapy and other treatment-related factors on mid-term to long-term cognitive sequelae in low-grade gliomas: a comparative study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1278-0

Improved, personalized treatment of glioma necessitates long-term follow-up of cognitive functioning

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1278-0

Cognitive rehabilitation in patients with gliomas: a randomized, controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1278-0

[The Maastricht aging study (MAAS). The longitudinal perspective of cognitive aging]

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24162809

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Neurobehavioral status and health-related quality of life in newly diagnosed high-grade glioma patients.

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24162809

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1007/S11060-013-1278-0

1 reference

Dimensions Publication ID

14 December 2017

1051689207

0 references

1 reference